Host defenses in patients with cystic fibrosis: modulation by Pseudomonas aeruginosa.
D000268:Adhesiveness; D000917:Antibody Formation; D000936:Antigen-Antibody Complex; D001427:Bacterial Toxins / Q000276:immunology; D001770:Blood Bactericidal Activity; D003165:Complement System Proteins / Q000276:immunology; D003550:Cystic Fibrosis / Q000276:immunology / Q000382:microbiology*; D005098:Exotoxins / Q000276:immunology; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D006967:Hypersensitivity / Q000276:immunology; D007111:Immunity, Cellular; D007136:Immunoglobulins / Q000502:physiology; D007962:Leukocytes / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D009061:Mouth Mucosa / Q000382:microbiology; D009093:Mucus / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D009895:Opsonin Proteins; D010447:Peptide Hydrolases / Q000276:immunology; D010587:Phagocytosis; D011135:Polysaccharides, Bacterial / Q000276:immunology; D011552:Pseudomonas Infections / Q000276:immunology*; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D012137:Respiratory System / Q000382:microbiology
D000936:Antigen-Antibody Complex; D001427:Bacterial Toxins; D005098:Exotoxins; D006023:Glycoproteins; D007136:Immunoglobulins; D009895:Opsonin Proteins; D011135:Polysaccharides, Bacterial; D003165:Complement System Proteins; D010447:Peptide Hydrolases